Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

GOP Continuing Resolution Would Fund FDA At 2024 Levels

Mar 11 2025

• By Sarah Karlin-Smith

US Capitol at sunset. — Congress narrowly avoided a government shutdown, but pharma priorities were shutout. (Shutterstock)

Related Content

Congress Gives US FDA Austere Budget But Seeks Boosts On Inspections, IT, And ALS Activities

Mar 05 2024

US Government Keeps Lights On But Pharma Priorities For PBM Reform, Rare Diseases Nixed

Dec 21 2024

US FDA Still Reviewing Rare Pediatric Disease Designation Requests Despite Program Lapse

Jan 07 2025

Rare, Pediatric Drug Development and Reimbursement Boosted In Shaky US Spending Deal

Dec 19 2024

Chaos In Washington Raises Shutdown Fears, PBM And Rare Disease Priorities Cut From CR

Dec 20 2024

More from Medtech Insight

More from Legislation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window